NASDAQ · EMBC

Embecta Corp.

Healthcare · Drug Manufacturers - Specialty & Generic

$4.97

Up+$0.01 (+0.20%)

Updated Aug 28, 2026, 12:08 PM

SID Score

5.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Price performance

EMBC price history

1M range · 0 trading sessions · Daily adjusted prices

Data unavailable

Market data is busy. Please try again shortly.

The latest Smart Investors Daily articles mentioning EMBC.

The latest Smart Investors Daily articles mentioning EMBC.

Stock researchCompany · Earnings

Company

Market Activity

Research & News

EMBC research

Reported results, surprises, and transcripts.

Report date	Quarter	Year	EPS actual	EPS estimate	EPS surprise	Revenue
Aug 7, 2026	Q3	2,026	$0.56	$0.26	+1.15%	271.7M
May 8, 2026	Q2	2,026	—	$0.42	—	—
May 5, 2026	Q2	2,026	$0.27	$0.42	-0.36%	221.8M
Feb 6, 2026	Q1	2,026	—	$0.6834	—	—
Feb 5, 2026	Q1	2,026	$0.71	$0.67	+0.06%	261.2M
Feb 4, 2026	Q1	2,026	—	$0.6834	—	—
Sep 30, 2025	Q4	2,025	$0.50	$0.5474	-8.66%	—
Jun 30, 2025	Q3	2,025	$1.12	$0.7905	+41.68%	—
Mar 31, 2025	Q2	2,025	$0.70	$0.5386	+29.97%	—
Dec 31, 2024	Q1	2,025	$0.65	$0.4514	+44.00%	—
Sep 30, 2024	Q4	2,024	$0.45	$0.3692	+21.89%	—
Jun 30, 2024	Q3	2,024	$0.74	$0.4733	+56.35%	—
Mar 31, 2024	Q2	2,024	$0.67	$0.408	+64.22%	—
Dec 31, 2023	Q1	2,024	$0.61	$0.4641	+31.44%	—
Sep 30, 2023	Q4	2,023	$0.59	$0.4055	+45.50%	—
Jun 30, 2023	Q3	2,023	$0.26	$0.4692	-44.59%	—
Mar 31, 2023	Q2	2,023	$0.24	$0.4964	-51.65%	—
Dec 31, 2022	Q1	2,023	$0.96	$0.5253	+82.75%	—
Sep 30, 2022	Q4	2,022	$1.18	$0.6783	+73.96%	—
Jun 30, 2022	Q3	2,022	$1.30	$0.8874	+46.50%	—